Documenting the global burden of cardiovascular disease: a major achievement but still a work in progress.

The publication of the 1990 Global Burden of Disease (GBD) was a seminal moment for international health.1 In a world characterized by what has been termed a “scandal of ignorance,”2 where most peoples’ existence was never recorded, the authors undertook the heroic task of estimating not only how many people were dying and from what conditions but also how many were living with disability. By combining these measures to create the disability-adjusted life year, they changed the global health discourse forever. The task was enormous. They had to include all countries, including many that had attracted virtually no attention from health researchers and that lacked vital registration systems. They scoured the world for data, extracting information from dusty archives, and analyzed surveys that had been forgotten. Article see p 1483 and p 1493 However, existing data only went so far; alternatives were needed. The authors created complex (although, for some, virtually incomprehensible) models that established relationships in countries with data for variables such as national income and patterns of disease and then extrapolated to countries and regions or for conditions where data were unavailable to fill the many gaps.3 They also developed ambitious methodologic and empiric approaches to understand associations between mortality and the much less well researched disability and to measure the contribution of different disease states to both.4 These efforts, in turn, have stimulated a massive increase in data collection, with expansions in vital registration systems, sentinel surveillance sites,5 and methodologic refinements of instruments such as verbal autopsy.6 As a result, the 2010 GBD took our understanding of the health of the world’s population to a new level,7 although, as the accompanying articles in this issue of Circulation demonstrate, there are still many issues to be resolved.8,9 However, …

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  C. Murray,et al.  The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study , 2014, Circulation.

[3]  S. Yusuf,et al.  Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies , 2014, PloS one.

[4]  S. Yusuf,et al.  Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries. , 2013, American heart journal.

[5]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[6]  Pablo Perel,et al.  The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review , 2013, PLoS medicine.

[7]  J. Guirguis-Blake Pharmacotherapy for mild hypertension. , 2013, American family physician.

[8]  Martin McKee,et al.  Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening , 2013, The Lancet.

[9]  David A. Leon,et al.  Components and possible determinants of decrease in Russian mortality in 2004-2010 , 2013 .

[10]  C. Murray,et al.  Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study , 2013, Circulation.

[11]  A. Haines,et al.  Embedding non-communicable diseases in the post-2015 development agenda , 2013, The Lancet.

[12]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[13]  Alan D. Lopez,et al.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[14]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[15]  S. Yusuf,et al.  n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. , 2012, The New England journal of medicine.

[16]  M. Mckee,et al.  Manufacturing Epidemics: The Role of Global Producers in Increased Consumption of Unhealthy Commodities Including Processed Foods, Alcohol, and Tobacco , 2012, PLoS medicine.

[17]  R. Dandona,et al.  The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. , 2012, Journal of the American College of Cardiology.

[18]  R. Collins,et al.  China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.

[19]  S. Yusuf,et al.  Urinary sodium and potassium excretion and risk of cardiovascular events. , 2011, JAMA.

[20]  S. Yusuf,et al.  Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey , 2011, The Lancet.

[21]  Martin McKee,et al.  Environmental Profile of a Community's Health (EPOCH): An Instrument to Measure Environmental Determinants of Cardiovascular Health in Five Countries , 2010, PloS one.

[22]  Martin McKee,et al.  The World Health Report 2000: 10 years on. , 2010, Health policy and planning.

[23]  Octavio Rodríguez On the development agenda , 2010 .

[24]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[25]  N. Dhingra,et al.  Prospective Study of One Million Deaths in India: Rationale, Design, and Validation Results , 2005, PLoS medicine.

[26]  R. Peto,et al.  Verbal autopsy of 80,000 adult deaths in Tamilnadu, South India , 2004, BMC public health.

[27]  J. Critchley,et al.  Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999 , 2004, Circulation.

[28]  Simon Capewell,et al.  Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.

[29]  Jan J Barendregt,et al.  A generic model for the assessment of disease epidemiology: the computational basis of DisMod II , 2003, Population health metrics.

[30]  L. Pilotto [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[31]  H. Imano,et al.  [Changes in 24-hour urinary excretion of sodium and potassium in a community-based heath education program on salt reduction]. , 1999, [Nihon koshu eisei zasshi] Japanese journal of public health.

[32]  R. Feachem Disease and Mortality in Sub-Saharan Africa , 1991 .

[33]  Stephen S. Lim,et al.  Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. , 2014, Bulletin of the World Health Organization.

[34]  W. Elliott Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events , 2012 .

[35]  J D Ainsworth,et al.  IMPACT: A Generic Tool for Modelling and Simulating Public Health Policy , 2011, Methods of Information in Medicine.

[36]  M. Mckee,et al.  Strategies for health services , 2009 .

[37]  S. Clark,et al.  Levels and Patterns of Mortality at INDEPTH Demographic Surveillance Systems , 2006 .

[38]  J. Murray,et al.  The Global Burden of Disease , 1996 .